Hepatitis C presents a serious health threat worldwide. Some 150 million individuals are currently living with the virus, and nearly four million people become infected every year.
Hepatitis C is particularly devastating in Eastern Europe and Central Asia, where infection is strongly correlated with injection drug use. Yet, the cost of treatment remains prohibitive to most people in the region. Lack of effective treatment not only causes serious harm to individuals, it directly impacts the ability of countries to respond to the growing HIV epidemic.
This report produced by the Access to Essential Medicines Initiative of the Open Society Public Health Program seeks to help advocates expand hepatitis C treatment in Eastern Europe and Central Asia.
The report covers the following topics:
- Basic information about hepatitis C, including prevalence, means of transmission, disease progression, and health consequences
- The double impact of hepatitis and HIV coinfection
- Hepatitis testing and barriers to identifying infection
- Hepatitis treatments and availability of medicines
- Strategies for reducing the cost of treatment
- Barriers to treatment for active drug users
- Building civil society advocacy focused on hepatitis
The report is available in English and Russian.
Download
-
Shining a Light on a Hidden Epidemic (English) (231.35 Kb pdf file)
Download the report in English.
-
Shining a Light on a Hidden Epidemic (Russian) (336.76 Kb pdf file)
Download the report in Russian.
Read more
Drug Policy
The Prescription for Saving Lives
A person dies every five minutes from overdose in the United States. We have the means to dramatically reduce those numbers. But the medication naloxone is suddenly scarce and prices are too high. What needs to happen next to save lives.
Faith and Healing
Q&A: Preaching Harm Reduction
By bringing harm reduction to the faith community, Faith in Public Life is using the church to save lives in the face of the overdose crisis.
Event Recap
The Way the U.S. Regulates Methadone Isn’t Working
A new documentary takes a close look at how methadone is used in the United States today, while raising profound questions about the purpose of antidrug policies and the benefits of harm reduction.